
Brain resilience switch: CgA protein shields against Alzheimer's symptoms in mice
UCSD researchers identify chromogranin A (CgA) as a key driver linking amyloid-beta/tau pathology to cognitive decline: mice lacking CgA still develop Alzheimer’s brain changes but remain cognitively sharp, revealing innate resilience mechanisms and a potential preventive target, though human confirmation and safety considerations are needed, and some authors have industry ties.










